Imricor Medical (Australia) Today
| IMR Stock | 1.44 0.01 0.70% |
Performance17 of 100
| Odds Of DistressOver 63
|
Imricor Medical is selling for under 1.44 as of the 1st of February 2025; that is 0.70 percent increase since the beginning of the trading day. The stock's last reported lowest price was 1.38. Imricor Medical has more than 63 % chance of experiencing financial distress in the next few years of operation. However, it had a very solid returns during the last 90 days. The performance scores are derived for the period starting the 5th of August 2024 and ending today, the 1st of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Imricor Medical is entity of Australia. It is traded as Stock on AU exchange. The company has 270.18 M outstanding shares. More on Imricor Medical Systems
Moving together with Imricor Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Imricor Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Imricor Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Imricor Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Steve Wedan | ||||
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
Imricor Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Imricor Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsImricor Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Imricor Medical's financial leverage. It provides some insight into what part of Imricor Medical's total assets is financed by creditors.
| |||||
Imricor Medical Systems (IMR) is traded on Australian Securities Exchange in Australia and employs 7 people. Imricor Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 386.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Imricor Medical's market, we take the total number of its shares issued and multiply it by Imricor Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Imricor Medical Systems operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 270.18 M outstanding shares.
Imricor Medical generates negative cash flow from operations
Check Imricor Medical Probability Of Bankruptcy
Ownership AllocationImricor Medical Systems has a total of 270.18 Million outstanding shares. Imricor Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Imricor Ownership Details
Imricor Medical Systems Risk Profiles
Although Imricor Medical's alpha and beta are two of the key measurements used to evaluate Imricor Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.62 | |||
| Semi Deviation | 3.63 | |||
| Standard Deviation | 5.85 | |||
| Variance | 34.21 |
Imricor Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Imricor Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Imricor Medical Corporate Management
Elected by the shareholders, the Imricor Medical's board of directors comprises two types of representatives: Imricor Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imricor. The board's role is to monitor Imricor Medical's management team and ensure that shareholders' interests are well served. Imricor Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imricor Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gregg Stenzel | Chief Officer | Profile | |
| Nick Twohy | Vice Development | Profile | |
| Greg Englehardt | Senior Sales | Profile | |
| Kobe Lizheng | Company Agent | Profile |
Additional Tools for Imricor Stock Analysis
When running Imricor Medical's price analysis, check to measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.